Safety and immunogenicity of a recombinant Borrelia burgdorferi outer surface protein A vaccine against lyme disease in healthy children and adolescents: a randomized controlled trial.

Source:http://linkedlifedata.com/resource/pubmed/id/11433064

Download in:

View as

General Info

PMID
11433064